|
1
|
No authors listed: Oral cancer-the fight
must go on against all odds…. Evid Based Dent. 23:4–5. 2022.
View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuo TJ, Jean YH, Shih PC, Cheng SY, Kuo
HM, Lee YT, Lai YC, Tseng CC, Chen WF and Wen ZH: Stellettin
B-induced oral cancer cell death via endoplasmic reticulum
stress-mitochondrial apoptotic and autophagic signaling pathway.
Int J Mol Sci. 23:88132022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kruijtzer CM, Beijnen JH and Schellens JH:
Improvement of oral drug treatment by temporary inhibition of drug
transporters and/or cytochrome P450 in the gastrointestinal tract
and liver: An overview. Oncologist. 7:516–530. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dobler C, Jost T, Hecht M, Fietkau R and
Distel L: Senescence induction by combined ionizing radiation and
DNA damage response inhibitors in head and neck squamous cell
carcinoma cells. Cells. 9:20122020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pei L and Melmed S: Isolation and
characterization of a pituitary tumor-transforming gene (PTTG). Mol
Endocrinol. 11:433–441. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jallepalli PV, Waizenegger IC, Bunz F,
Langer S, Speicher MR, Peters JM, Kinzler KW, Vogelstein B and
Lengauer C: Securin is required for chromosomal stability in human
cells. Cell. 105:445–457. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vlotides G, Eigler T and Melmed S:
Pituitary tumor-transforming gene: Physiology and implications for
tumorigenesis. Endocr Rev. 28:165–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teveroni E, Di Nicuolo F, Bianchetti G,
Epstein AL, Grande G, Maulucci G, De Spirito M, Pontecorvi A,
Milardi D and Mancini F: Nuclear localization of PTTG1 promotes
migration and invasion of seminoma tumor through activation of
MMP-2. Cancers (Basel). 13:2122021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Yu R and Melmed S: Mice lacking
pituitary tumor transforming gene show testicular and splenic
hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell
cycle progression, and premature centromere division. Mol
Endocrinol. 15:1870–1879. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lai Y, Xin D, Bai J, Mao Z and Na Y: The
important anti-apoptotic role and its regulation mechanism of PTTG1
in UV-induced apoptosis. J Biochem Mol Biol. 40:966–972.
2007.PubMed/NCBI
|
|
13
|
Kim DS, Franklyn JA, Smith VE, Stratford
AL, Pemberton HN, Warfield A, Watkinson JC, Ishmail T, Wakelam MJ
and McCabe CJ: Securin induces genetic instability in colorectal
cancer by inhibiting double-stranded DNA repair activity.
Carcinogenesis. 28:749–759. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Read ML, Fong JC, Modasia B, Fletcher A,
Imruetaicharoenchoke W, Thompson RJ, Nieto H, Reynolds JJ, Bacon A,
Mallick U, et al: Elevated PTTG and PBF predicts poor patient
outcome and modulates DNA damage response genes in thyroid cancer.
Oncogene. 36:5296–5308. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pei L: Identification of c-myc as a
down-stream target for pituitary tumor-transforming gene. J Biol
Chem. 276:8484–8491. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernal JA, Luna R, Espina A, Lázaro I,
Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M and
Pintor-Toro JA: Human securin interacts with p53 and modulates
p53-mediated transcriptional activity and apoptosis. Nat Genet.
32:306–311. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao LJ, Hsu YH, Yu CH, Chiang CP, Jhan
JR, Chang LC, Lin JJ and Lou PJ: Association of pituitary tumor
transforming gene expression with early oral tumorigenesis and
malignant progression of precancerous lesions. Head Neck.
33:719–726. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang E, Liu S, Xu Z, Huang S, Tan X, Sun
C and Lu L: Pituitary tumor-transforming gene 1 (PTTG1) is
overexpressed in oral squamous cell carcinoma (OSCC) and promotes
migration, invasion and epithelial-mesenchymal transition (EMT) in
SCC15 cells. Tumour Biol. 35:8801–8811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Piskorz WM and Cechowska-Pasko M:
Senescence of tumor cells in anticancer therapy-beneficial and
detrimental effects. Int J Mol Sci. 23:110822022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Campisi J and d'Adda di Fagagna F:
Cellular senescence: When bad things happen to good cells. Nat Rev
Mol Cell Biol. 8:729–740. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Childs BG, Baker DJ, Kirkland JL, Campisi
J and van Deursen JM: Senescence and apoptosis: Dueling or
complementary cell fates? EMBO Rep. 15:1139–1153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gorgoulis V, Adams PD, Alimonti A, Bennett
DC, Bischof O, Bishop C, Campisi J, Collado M, Evangelou K,
Ferbeyre G, et al: Cellular senescence: Defining a path forward.
Cell. 179:813–827. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hernandez-Segura A, Nehme J and Demaria M:
Hallmarks of cellular senescence. Trends Cell Biol. 28:436–453.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herranz N and Gil J: Mechanisms and
functions of cellular senescence. J Clin Invest. 128:1238–1246.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
HAYFLICK L: THE LIMITED IN VITRO LIFETIME
OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res. 37:614–636. 1965.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen YC, Hsieh HH, Chang HC, Wang HC, Lin
WJ and Lin JJ: CDC25B induces cellular senescence and correlates
with tumor suppression in a p53-dependent manner. J Biol Chem.
296:1005642021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jung SH, Hwang HJ, Kang D, Park HA, Lee
HC, Jeong D, Lee K, Park HJ, Ko YG and Lee JS: mTOR kinase leads to
PTEN-loss-induced cellular senescence by phosphorylating p53.
Oncogene. 38:1639–1650. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jeoung DI, Tang B and Sonenberg M:
Induction of tumor suppressor p21 protein by kinase inhibitors in
MCF-7 cells. Biochem Biophys Res Commun. 214:361–366. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Englund DA, Jolliffe A, Aversa Z, Zhang X,
Sturmlechner I, Sakamoto AE, Zeidler JD, Warner GM, McNinch C,
White TA, et al: p21 induces a senescence program and skeletal
muscle dysfunction. Mol Metab. 67:1016522023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bologna-Molina R, Mosqueda-Taylor A,
Molina-Frechero N, Mori-Estevez AD and Sánchez-Acuña G: Comparison
of the value of PCNA and Ki-67 as markers of cell proliferation in
ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 18:e174–e179.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Loftus LV, Amend SR and Pienta KJ:
Interplay between cell death and cell proliferation reveals new
strategies for cancer therapy. Int J Mol Sci. 23:47232022.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mirzayans R and Murray D: Do TUNEL and
other apoptosis assays detect cell death in preclinical studies?
Int J Mol Sci. 21:90902020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meng C, Zou Y, Hong W, Bao C and Jia X:
Estrogen-regulated PTTG1 promotes breast cancer progression by
regulating cyclin kinase expression. Mol Med. 26:332020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang G, Xiog Y, Wang G, Li W, Tang T, Sun
J and Li J: miR-374c-5p regulates PTTG1 and inhibits cell growth
and metastasis in hepatocellular carcinoma by regulating
epithelial-mesenchymal transition. Mol Med Rep. 25:1482022.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang H, He Z, Qiu L, Wei J, Gong X, Xian
M, Chen Z, Cui Y, Fu S, Zhang Z, et al: PRR11 promotes cell
proliferation by regulating PTTG1 through interacting with E2F1
transcription factor in pan-cancer. Front Mol Biosci. 9:8773202022.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee SS, Choi JH, Lim SM, Kim GJ, Lee SK
and Jeon YK: Alteration of pituitary tumor transforming gene 1 by
microRNA-186 and 655 regulates invasion ability of human oral
squamous cell carcinoma. Int J Mol Sci. 22:10212021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu J, Cao J, Topatana W, Juengpanich S, Li
S, Zhang B, Shen J, Cai L, Cai X and Chen M: Targeting mutant p53
for cancer therapy: Direct and indirect strategies. J Hematol
Oncol. 14:1572021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nakagaki T, Tamura M, Kobashi K, Koyama R,
Fukushima H, Ohashi T, Idogawa M, Ogi K, Hiratsuka H, Tokino T and
Sasaki Y: Profiling cancer-related gene mutations in oral squamous
cell carcinoma from Japanese patients by targeted amplicon
sequencing. Oncotarget. 8:59113–59122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hauser U, Balz V, Carey TE, Grénman R, Van
Lierop A, Scheckenbach K and Bier H: Reliable detection of p53
aberrations in squamous cell carcinomas of the head and neck
requires transcript analysis of the entire coding region. Head
Neck. 24:868–873. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Alhmoud JF, Woolley JF, Al Moustafa AE and
Malki MI: DNA damage/repair management in cancers. Cancers (Basel).
12:10502020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yousefzadeh M, Henpita C, Vyas R,
Soto-Palma C, Robbins P and Niedernhofer L: DNA damage-how and why
we age? Elife. 10:e628522021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Trenner A and Sartori AA: Harnessing DNA
double-strand break repair for cancer treatment. Front Oncol.
9:13882019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abuetabh Y, Wu HH, Chai C, Al Yousef H,
Persad S, Sergi CM and Leng R: DNA damage response revisited: The
p53 family and its regulators provide endless cancer therapy
opportunities. Exp Mol Med. 54:1658–1669. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cimprich KA and Cortez D: ATR: An
essential regulator of genome integrity. Nat Rev Mol Cell Biol.
9:616–627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bonner WM, Redon CE, Dickey JS, Nakamura
AJ, Sedelnikova OA, Solier S and Pommier Y: GammaH2AX and cancer.
Nat Rev Cancer. 8:957–967. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Engeland K: Cell cycle regulation:
p53-p21-RB signaling. Cell Death Differ. 29:946–960. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ho CJ, Lin RW, Zhu WH, Wen TK, Hu CJ, Lee
YL, Hung TI and Wang C: Transcription-independent and -dependent
p53-mediated apoptosis in response to genotoxic and non-genotoxic
stress. Cell Death Discov. 5:1312019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee TK, Lau TC and Ng IO:
Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell
lines. Cancer Chemother Pharmacol. 49:78–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kciuk M, Gielecińska A, Mujwar S, Kołat D,
Kałuzińska-Kołat Ż, Celik I and Kontek R: Doxorubicin-an agent with
multiple mechanisms of anticancer activity. Cells. 12:6592023.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yun UJ, Lee JH, Shim J, Yoon K, Goh SH, Yi
EH, Ye SK, Lee JS, Lee H, Park J, et al: Anti-cancer effect of
doxorubicin is mediated by downregulation of HMG-Co A reductase via
inhibition of EGFR/Src pathway. Lab Invest. 99:1157–1172. 2019.
View Article : Google Scholar : PubMed/NCBI
|
